IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells

Open Access

Peer-reviewed

Research Article

Bastian Schilling,

Affiliation University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
⨯
Malgorzata Harasymczuk,

Affiliation University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
⨯
Patrick Schuler,

Affiliation University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
⨯
James Egan,

Affiliation IRX Therapeutic Inc., Farmingdale, New York, United States of America
⨯
Soldano Ferrone,

Affiliation University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
⨯
Theresa L. Whiteside

* E-mail: whitesidetl@upmc.edu

Affiliation University of Pittsburgh, Department of Pathology and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America
⨯

Reader Comments (0)

Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.